Filing Details
- Accession Number:
- 0001213900-19-017904
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-12 21:15:36
- Reporting Period:
- 2019-09-11
- Accepted Time:
- 2019-09-12 21:15:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711754 | Inmune Bio Inc. | INMB | Biological Products, (No Disgnostic Substances) (2836) | 475205835 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1767037 | William Mark Lowdell | C/O Inmune Bio Inc., 1200 Prospect Street, Suite 525 La Jolla CA 92037 | Chief Scientific Officer | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-11 | 2,918 | $6.23 | 1,506,251 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased an aggregate of 2,918 shares of the Registrant's common stock on September 11, 2019 in an open market transaction.
Billionaire Hedge Funds
